Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



HERSHBERG ROBERT Create: Alert

All | News | Filings
Date FiledTypeDescription
06/07/2023 4 HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC
Txns: Granted 40,000 options to buy @ $5.52, valued at $220.8k
03/08/2023 4 HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp
Txns: Granted 14,775 shares @ $0
Granted 23,329 options to buy @ $8.46, valued at $197.4k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 18,145 shares @ $0
Granted 36,290 options to buy @ $6.2, valued at $225k
06/13/2022 4 HERSHBERG ROBERT (Director) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Granted 18,000 options to buy @ $4.18, valued at $75.2k
06/13/2022 4 HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC
Txns: Granted 8,650 shares @ $0
Granted 11,893 options to buy @ $23.48, valued at $279.2k
06/06/2022 4 HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC
Txns: Sold 672 shares @ $22.75, valued at $15.3k
04/28/2022 3 HERSHBERG ROBERT (President and CEO) has filed a Form 3 on HilleVax, Inc.
04/18/2022 4 HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc
Txns: Exercised 3,306 options to buy @ $0
01/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 693 shares @ $0
10/05/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 572 shares @ $0
09/21/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $28.83, valued at $432.5k
07/06/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 347 shares @ $0
06/17/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc
Txns: Exercised 5,520 options to buy @ $0
Granted 3,890 options to buy @ $0
06/04/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on FATE THERAPEUTICS INC
Txns: Granted 2,681 shares @ $0
Granted 4,334 options to buy @ $68.94, valued at $298.8k
04/22/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Converted 6,250 shares @ $0
Converted 12,500 options to buy @ $18, valued at $225k
Converted 525,000 options to buy @ $2.22, valued at $1.2M
04/19/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on RECURSION PHARMACEUTICALS, INC.
Txns: Granted 6,250 shares @ $0
Granted 12,500 options to buy @ $18, valued at $225k
04/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/15/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
03/17/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc
Txns: Sold 4 shares @ $63.58, valued at $254.3
Sold 282 shares @ $66.03, valued at $18.6k
Sold 1,214 shares @ $67.16, valued at $81.5k
Exercised 1,500 options to buy @ $11.2, valued at $16.8k
03/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/18/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/20/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp
Txns: Sold 1,378 shares @ $66.34, valued at $91.4k
Sold 622 shares @ $67.05, valued at $41.7k
Exercised 2,000 options to buy @ $0.45, valued at $900
01/19/2021 4 HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc
Txns: Sold 709 shares @ $71.77, valued at $50.9k
Sold 410 shares @ $72.91, valued at $29.9k
Sold 291 shares @ $73.66, valued at $21.4k
Sold 90 shares @ $74.55, valued at $6.7k
Exercised 1,500 options to buy @ $11.2, valued at $16.8k
12/16/2020 4 HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp
Txns: Sold 1,759 shares @ $55.78, valued at $98.1k
Sold 241 shares @ $57.01, valued at $13.7k
Exercised 2,000 options to buy @ $0.45, valued at $900
12/16/2020 4 HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc
Txns: Sold 688 shares @ $68.68, valued at $47.3k
Sold 812 shares @ $69.88, valued at $56.7k
Exercised 1,500 options to buy @ $11.2, valued at $16.8k
12/07/2020 4 HERSHBERG ROBERT (Director) has filed a Form 4 on Silverback Therapeutics, Inc.
Txns: Granted 73,251 options to buy @ $21, valued at $1.5M
12/03/2020 3 HERSHBERG ROBERT (Director) has filed a Form 3 on Silverback Therapeutics, Inc.
11/18/2020 4 HERSHBERG ROBERT (Director) has filed a Form 4 on Adaptive Biotechnologies Corp
Txns: Sold 1,777 shares @ $47.6, valued at $84.6k
Sold 223 shares @ $48.41, valued at $10.8k
Exercised 2,000 options to buy @ $0.45, valued at $900
11/18/2020 4 HERSHBERG ROBERT (Director) has filed a Form 4 on NanoString Technologies Inc
Txns: Sold 754 shares @ $46.31, valued at $34.9k
Sold 746 shares @ $47.03, valued at $35.1k
Exercised 1,500 options to buy @ $11.2, valued at $16.8k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy